Clinicaltrials.gov is a web-based resource for information about federally and privately supported clinical research in human volunteers conducted around the world. Clinicaltrials.gov provides a single entry point to find clinical studies, find out what stage the research is in, learn about any risks of participating in the trial, find out where you can get more information from and more. Clinicaltrials.gov is the world’s largest source of information on clinical research. It is published by the National Institutes of Health and includes all clinical trials in the United States.
Clinicaltrials.gov is the registry listing of federally and privately supported clinical trials conducted in the United States or by U.S. organizations anywhere in the world. ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical trials conducted around the world. ClinicalTrials.gov gives you access to information about federally and privately supported clinical studies on conditions that affect your health. Find out about the latest treatments for cancer, heart disease and pain, as well as new therapies for behavioral health conditions like depression or schizophrenia. Clinicaltrials.gov is one of the most comprehensive databases of clinical research studies in human volunteers. It provides trial registration details and study results for you to review before participating in a clinical trial. You can search Clinicaltrials.gov to find trials that match your interests, or search our Library of Research Organisations to find out more about them.
This website is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world that are being carried out under the auspices of regulatory agencies and ethics committees. Clinicaltrials.gov is the U.S. government’s clinical trials website, offering a database of federally and privately supported clinical trials conducted in the United States and around the world. Over 300 million people worldwide suffer from diseases that could benefit from clinical trials, yet only one percent of those who could benefit from participation in a trial enroll. The Controlled Substances Act (CSA) of 1970 placed special requirements on entities conducting clinical research on Schedule I drugs such as marijuana, including registration with DEA and submission of an Investigational New Drug (IND) application before beginning patient enrollment. Ensuring patients can access the therapeutic uses of marijuana consistent with scientific evidence is a high priority for us at NIDA. To this end, we have been very pleased by recent policy changes that permit more experienced researchers to perform scientific studies about marijuana without having to submit an IND application first.
Yeni yazılarımızdan hemen haberdar olmak için kayıt olun.